Addressing the Knowledge Gap in Biologics & Biosimilars: Is a Board Certified Biologics and Biosimilars Program the Answer?
Published: | Updated:
Life sciences professionals will need to keep up with market demand for biologics and biosimilars.
Kiana Dixson
Advertisement
Articles by Kiana Dixson
Advertisement
Latest Updated Articles
Addressing the Knowledge Gap in Biologics & Biosimilars: Is a Board Certified Biologics and Biosimilars Program the Answer?Published: November 4th 2022 | Updated: November 12th 2022
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Leading in the Psychedelic Space: Q&A with Tarek Rabah
4
Pharmaceutical Executive Daily: FDA Approves Hernexeos
5